AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
- Combined transactions will strengthen balance sheet and reduce outstanding debt by more than 90% - - 7 million of additional capital via cash-exercise warrants - - Daewoong has entered binding term sheet for exchange of 1.5 million new note due 2030 and 8 million cash-exercise warrants totaling over $8M of potential proceeds - - Transactions expected to support uninterrupted advancement of AEON’s A ...